title: In vitro studies of dasatinib, its targets and predictors of sensitivity.
authors.forename: Lucia B
authors.initials: LB
authors.lastname: Jilaveanu
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Zito
authors.forename: Saadia A
authors.initials: SA
authors.lastname: Aziz
authors.forename: Ashok
authors.initials: A
authors.lastname: Chakraborty
authors.forename: Michael A
authors.initials: MA
authors.lastname: Davies
authors.forename: Robert L
authors.initials: RL
authors.lastname: Camp
authors.forename: David L
authors.initials: DL
authors.lastname: Rimm
authors.forename: Arkadiusz
authors.initials: A
authors.lastname: Dudek
authors.forename: Mario
authors.initials: M
authors.lastname: Sznol
authors.forename: Harriet M
authors.initials: HM
authors.lastname: Kluger
mesh_terms: D045744:Cell Line, Tumor; D002986:Clinical Trials as Topic; D000069439:Dasatinib; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000201:enzymology* / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology; D013844:Thiazoles / Q000627:therapeutic use*; D019061:src-Family Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D019061:src-Family Kinases; D000069439:Dasatinib